icrf 193 has been researched along with adenosine diphosphate in 1 studies
| Studies (icrf 193) | Trials (icrf 193) | Recent Studies (post-2010) (icrf 193) | Studies (adenosine diphosphate) | Trials (adenosine diphosphate) | Recent Studies (post-2010) (adenosine diphosphate) |
|---|---|---|---|---|---|
| 155 | 0 | 30 | 23,989 | 498 | 3,114 |
| Protein | Taxonomy | icrf 193 (IC50) | adenosine diphosphate (IC50) |
|---|---|---|---|
| Chain A, Kinesin-like protein KIF11 | Homo sapiens (human) | 0.45 | |
| Heat shock 70 kDa protein 1A | Homo sapiens (human) | 0.5 | |
| Sensor protein kinase WalK | Staphylococcus aureus | 7.189 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsieh, TS; Hu, T; Sage, H | 1 |
1 other study(ies) available for icrf 193 and adenosine diphosphate
| Article | Year |
|---|---|
ATPase domain of eukaryotic DNA topoisomerase II. Inhibition of ATPase activity by the anti-cancer drug bisdioxopiperazine and ATP/ADP-induced dimerization.
Topics: Adenosine Diphosphate; Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Cross-Linking Reagents; Diketopiperazines; Dimerization; DNA Gyrase; DNA Primers; DNA Topoisomerases, Type II; Drosophila; Enzyme Inhibitors; Humans; Kinetics; Piperazines; Polymerase Chain Reaction; Topoisomerase II Inhibitors | 2002 |